Supernus Pharmaceuticals, Inc. (SUPN)
49.43
-1.77
(-3.46%)
USD |
NASDAQ |
May 15, 16:00
49.35
-0.08
(-0.16%)
After-Hours: 20:00
Supernus Pharmaceuticals Market Cap : 2.869B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 6.051B |
| Johnson & Johnson | 545.74B |
| Amphastar Pharmaceuticals, Inc. | 743.85M |
| Assertio Holdings, Inc. | 149.64M |
| Eli Lilly & Co. | 896.13B |
Market Cap Related Metrics
| PS Ratio | 3.630 |
| Price to Book Value | 2.664 |
| Price to Free Cash Flow | 34.29 |
| Price | 49.43 |
| Earnings Yield | -1.04% |